Dealing with MisinformationVideo Categories: 2018 AONN Midyear and Video Library
Dr Morganna Freeman addresses the issue of the pervasiveness of misinformation on the Internet.
Dr Wainberg and Dr Gerson identify some of the challenges of preclinical models versus clinical trials.
Dr Sanjiv Agarwala discusses the usefulness of MSI and TMB as novel biomarkers for various cancer types. His argument is that the first FDA approval of a therapy based on MSI rather than tumor type makes this biomarker useful, but TMB is not yet ready for “prime time.”